Did CEOs and officers buy or sell their own stock?
Open-market trades by the people who know the company best, with their own money.
Last 7 days: the stocks insiders bought and sold most
Stocks Koreans hold most · disclosed Last 7 days · open-market trades only
Bought most
Sold most
Whalegun
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
TScan TherapeuticsTCRX | Open-market buy | 25/12/19–25/12/23 | 25/12/23 | 161,801 sh3 trades | $0.90avg. | $145,620.9 | +2.1% | |
TScan TherapeuticsTCRX | Open-market buy | 25/05/19–25/05/20 | 25/05/21 | 2,588,794 sh2 trades | $1.20avg. | $3,106,552.8 | +48.3% | |
TScan TherapeuticsTCRX | Open-market buy | 24/12/12–24/12/13 | 24/12/16 | 131,800 sh2 trades | $2.93avg. | $385,718 | +2.5% | |
Weston Nichols10% Owner | TScan TherapeuticsTCRX | Open-market buy | 24/11/15 | 24/11/19 | 947 sh | $4.34 | $4,109.98 | +0.0% |
Barbara KlenckeDirector | TScan TherapeuticsTCRX | Open-market buy | 24/09/23 | 24/09/24 | 5,000 sh | $5.29 | $26,450 | +12.5% |
TScan TherapeuticsTCRX | Open-market buy | 24/08/23–24/08/26 | 24/08/27 | 10,000 sh2 trades | $5.61avg. | $56,100 | +33.3% | |
Zoran ZdraveskiSEE REMARKS | TScan TherapeuticsTCRX | Open-market sale | 24/08/23 | 24/08/27 | 164,686 sh | $5.78 | $951,885.08 | −97.2% |
TScan TherapeuticsTCRX | Open-market buy | 23/12/18–23/12/19 | 23/12/21 | 29,147 sh2 trades | $4.89avg. | $142,554.19 | +76.9% | |
Barbara KlenckeDirector | TScan TherapeuticsTCRX | Open-market buy | 23/12/14 | 23/12/18 | 5,000 sh | $5.08 | $25,400 | +20.0% |
Timothy J. BarberichDirector | TScan TherapeuticsTCRX | Open-market buy | 23/06/02 | 23/06/06 | 37,880 sh | $2.63 | $99,624.4 | No record |
TScan TherapeuticsTCRX | Open-market sale | 23/05/31 | 23/06/02 | 25,400 sh3 trades | $2.52avg. | $63,904 | −0.5% |